Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Social and Non-social Reward: A Preliminary Examination of Clinical Improvement and Neural Reactivity in Adolescents Treated With Behavioral Therapy for Anxiety and Depression.

Schwartz KTG, Kryza-Lacombe M, Liuzzi MT, Weersing VR, Wiggins JL.

Front Behav Neurosci. 2019 Aug 23;13:177. doi: 10.3389/fnbeh.2019.00177. eCollection 2019.

2.

An 18F-Labeled Poly(ADP-ribose) Polymerase Positron Emission Tomography Imaging Agent.

Zmuda F, Blair A, Liuzzi MC, Malviya G, Chalmers AJ, Lewis D, Sutherland A, Pimlott SL.

J Med Chem. 2018 May 10;61(9):4103-4114. doi: 10.1021/acs.jmedchem.8b00138. Epub 2018 Apr 19.

3.

Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor.

Paparin JL, Amador A, Badaroux E, Bot S, Caillet C, Convard T, Da Costa D, Dukhan D, Griffe L, Griffon JF, LaColla M, Leroy F, Liuzzi M, Giulia Loi A, McCarville J, Mascia V, Milhau J, Onidi L, Pierra C, Rahali R, Rosinosky E, Sais E, Seifer M, Surleraux D, Standring D, Dousson CB.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2634-2640. doi: 10.1016/j.bmcl.2017.01.017. Epub 2017 Jan 13.

PMID:
28416131
4.

Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase.

Pierra Rouvière C, Amador A, Badaroux E, Convard T, Da Costa D, Dukhan D, Griffe L, Griffon JF, LaColla M, Leroy F, Liuzzi M, Loi AG, McCarville J, Mascia V, Milhau J, Onidi L, Paparin JL, Rahali R, Sais E, Seifer M, Surleraux D, Standring D, Dousson C.

Bioorg Med Chem Lett. 2016 Sep 15;26(18):4536-4541. doi: 10.1016/j.bmcl.2016.01.042. Epub 2016 Jan 22.

PMID:
27520942
5.

Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor.

Dousson C, Alexandre FR, Amador A, Bonaric S, Bot S, Caillet C, Convard T, da Costa D, Lioure MP, Roland A, Rosinovsky E, Maldonado S, Parsy C, Trochet C, Storer R, Stewart A, Wang J, Mayes BA, Musiu C, Poddesu B, Vargiu L, Liuzzi M, Moussa A, Jakubik J, Hubbard L, Seifer M, Standring D.

J Med Chem. 2016 Mar 10;59(5):1891-8. doi: 10.1021/acs.jmedchem.5b01430. Epub 2016 Feb 3.

PMID:
26804933
6.

Design, synthesis and antiviral evaluation of 2'-C-methyl branched guanosine pronucleotides: the discovery of IDX184, a potent liver-targeted HCV polymerase inhibitor.

Sizun G, Pierra C, Peyronnet J, Badaroux E, Rabeson C, Benzaria-Prad S, Surleraux D, Loi AG, Musiu C, Liuzzi M, Seifer M, Standring D, Sommadossi JP, Gosselin G.

Future Med Chem. 2015;7(13):1675-700. doi: 10.4155/fmc.15.96. Epub 2015 Oct 1.

PMID:
26424162
7.

Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320.

Parsy CC, Alexandre FR, Bidau V, Bonnaterre F, Brandt G, Caillet C, Cappelle S, Chaves D, Convard T, Derock M, Gloux D, Griffon Y, Lallos LB, Leroy F, Liuzzi M, Loi AG, Moulat L, Chiara M, Rahali H, Roques V, Rosinovsky E, Savin S, Seifer M, Standring D, Surleraux D.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5427-36. doi: 10.1016/j.bmcl.2015.09.009. Epub 2015 Sep 5.

PMID:
26410074
8.

Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.

Alexandre FR, Brandt G, Caillet C, Chaves D, Convard T, Derock M, Gloux D, Griffon Y, Lallos L, Leroy F, Liuzzi M, Loi AG, Moulat L, Musiu C, Parsy C, Rahali H, Roques V, Seifer M, Standring D, Surleraux D.

Bioorg Med Chem Lett. 2015 Sep 15;25(18):3984-91. doi: 10.1016/j.bmcl.2015.07.020. Epub 2015 Jul 14.

PMID:
26231161
9.

Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors.

Kim J, Kwon J, Lee D, Jo S, Park DS, Choi J, Park E, Hwang JY, Ko Y, Choi I, Ju MK, Ahn J, Kim J, Han SJ, Kim TH, Cechetto J, Nam J, Ahn S, Sommer P, Liuzzi M, Lee J.

Bioorg Med Chem Lett. 2014 Dec 1;24(23):5473-7. doi: 10.1016/j.bmcl.2014.10.007. Epub 2014 Oct 23.

PMID:
25455487
10.

Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease.

Parsy C, Alexandre FR, Brandt G, Caillet C, Cappelle S, Chaves D, Convard T, Derock M, Gloux D, Griffon Y, Lallos L, Leroy F, Liuzzi M, Loi AG, Moulat L, Musiu C, Rahali H, Roques V, Seifer M, Standring D, Surleraux D.

Bioorg Med Chem Lett. 2014 Sep 15;24(18):4444-4449. doi: 10.1016/j.bmcl.2014.08.002. Epub 2014 Aug 9.

PMID:
25155387
11.

Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay.

Lee S, Lim D, Lee E, Lee N, Lee HG, Cechetto J, Liuzzi M, Freitas-Junior LH, Song JS, Bae MA, Oh S, Ayong L, Park SB.

J Med Chem. 2014 Sep 11;57(17):7425-34. doi: 10.1021/jm5009693. Epub 2014 Aug 26.

PMID:
25137549
12.

In vitro antiplasmodial activities and synergistic combinations of differential solvent extracts of the polyherbal product, Nefang.

Arrey Tarkang P, Franzoi KD, Lee S, Lee E, Vivarelli D, Freitas-Junior L, Liuzzi M, Nolé T, Ayong LS, Agbor GA, Okalebo FA, Guantai AN.

Biomed Res Int. 2014;2014:835013. doi: 10.1155/2014/835013. Epub 2014 Apr 27.

13.

Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A.

Germani A, Matrone A, Grossi V, Peserico A, Sanese P, Liuzzi M, Palermo R, Murzilli S, Campese AF, Ingravallo G, Canettieri G, Tezil T, Simone C.

Cancer Lett. 2014 Mar 1;344(1):110-118. doi: 10.1016/j.canlet.2013.10.035. Epub 2013 Nov 9.

PMID:
24215867
14.

High content screening of a kinase-focused library reveals compounds broadly-active against dengue viruses.

Cruz DJ, Koishi AC, Taniguchi JB, Li X, Milan Bonotto R, No JH, Kim KH, Baek S, Kim HY, Windisch MP, Pamplona Mosimann AL, de Borba L, Liuzzi M, Hansen MA, Duarte dos Santos CN, Freitas-Junior LH.

PLoS Negl Trop Dis. 2013;7(2):e2073. doi: 10.1371/journal.pntd.0002073. Epub 2013 Feb 21.

15.

Phenotypic MicroRNA Microarrays.

Kwon YJ, Heo JY, Kim HC, Kim JY, Liuzzi M, Soloveva V.

Microarrays (Basel). 2013 Apr 3;2(2):63-80. doi: 10.3390/microarrays2020063.

16.
17.

Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.

Kim J, Kwon J, Lee D, Jo S, Park DS, Choi J, Park E, Hwang JY, Ko Y, Choi I, Ju MK, Ahn J, Kim J, Han SJ, Kim TH, Cechetto J, Nam J, Ahn S, Sommer P, Liuzzi M, No Z, Lee J.

Bioorg Med Chem Lett. 2013 Jan 1;23(1):153-7. doi: 10.1016/j.bmcl.2012.10.134. Epub 2012 Nov 12.

PMID:
23206860
18.

Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.

Hwang JY, Windisch MP, Jo S, Kim K, Kong S, Kim HC, Kim S, Kim H, Lee ME, Kim Y, Choi J, Park DS, Park E, Kwon J, Nam J, Ahn S, Cechetto J, Kim J, Liuzzi M, No Z, Lee J.

Bioorg Med Chem Lett. 2012 Dec 15;22(24):7297-301. doi: 10.1016/j.bmcl.2012.10.123. Epub 2012 Nov 5.

PMID:
23159569
19.

Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response.

Grossi V, Liuzzi M, Murzilli S, Martelli N, Napoli A, Ingravallo G, Del Rio A, Simone C.

Cancer Biol Ther. 2012 Dec;13(14):1471-81. doi: 10.4161/cbt.22254. Epub 2012 Sep 17.

20.

Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.

Kim J, Lee D, Park C, So W, Jo M, Ok T, Kwon J, Kong S, Jo S, Kim Y, Choi J, Kim HC, Ko Y, Choi I, Park Y, Yoon J, Ju MK, Kim J, Han SJ, Kim TH, Cechetto J, Nam J, Sommer P, Liuzzi M, Lee J, No Z.

ACS Med Chem Lett. 2012 Jul 11;3(8):678-82. doi: 10.1021/ml300146q. eCollection 2012 Aug 9.

21.

[A dangerous loop].

Salvatore E, Diglio A, Stellato D, Aversano A, Liuzzi M, Morrone L.

G Ital Nefrol. 2012 Mar-Apr;29(2):248-9. Italian. No abstract available.

PMID:
22538955
22.

A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.

Kim J, Ok T, Park C, So W, Jo M, Kim Y, Seo M, Lee D, Jo S, Ko Y, Choi I, Park Y, Yoon J, Ju MK, Ahn J, Kim J, Han SJ, Kim TH, Cechetto J, Nam J, Liuzzi M, Sommer P, No Z.

Bioorg Med Chem Lett. 2012 Apr 1;22(7):2522-6. doi: 10.1016/j.bmcl.2012.01.133. Epub 2012 Feb 8.

PMID:
22374216
23.

[Diverse histological lesions in a patient with antiphospholipid syndrome (APS)].

Salvatore E, Luciani R, Di Palma A, Aversano A, Stellato D, Liuzzi M, Iele E, Martignetti V, Spagnuolo E, Morrone L.

G Ital Nefrol. 2011 Sep-Oct;28(5):537-40. Italian.

PMID:
22028268
24.

Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.

Alexandre FR, Amador A, Bot S, Caillet C, Convard T, Jakubik J, Musiu C, Poddesu B, Vargiu L, Liuzzi M, Roland A, Seifer M, Standring D, Storer R, Dousson CB.

J Med Chem. 2011 Jan 13;54(1):392-5. doi: 10.1021/jm101142k. Epub 2010 Dec 13.

PMID:
21142105
25.

The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part II.

Wu JP, Fleck R, Brickwood J, Capolino A, Catron K, Chen Z, Cywin C, Emeigh J, Foerst M, Ginn J, Hrapchak M, Hickey E, Hao MH, Kashem M, Li J, Liu W, Morwick T, Nelson R, Marshall D, Martin L, Nemoto P, Potocki I, Liuzzi M, Peet GW, Scouten E, Stefany D, Turner M, Weldon S, Zimmitti C, Spero D, Kelly TA.

Bioorg Med Chem Lett. 2009 Oct 1;19(19):5547-51. doi: 10.1016/j.bmcl.2009.08.054. Epub 2009 Aug 15.

PMID:
19716697
26.

Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication.

Vaillancourt FH, Pilote L, Cartier M, Lippens J, Liuzzi M, Bethell RC, Cordingley MG, Kukolj G.

Virology. 2009 Apr 25;387(1):5-10. doi: 10.1016/j.virol.2009.02.039. Epub 2009 Mar 21.

27.

Synthesis and antiviral evaluation of thieno[3,4-d]pyrimidine C-nucleoside analogues of 2',3'-dideoxy- and 2',3'-dideoxy-2',3'-didehydro-adenosine and -inosine.

Hamann M, Pierra C, Sommadossi JP, Musiu C, Vargiu L, Liuzzi M, Storer R, Gosselin G.

Bioorg Med Chem. 2009 Mar 15;17(6):2321-6. doi: 10.1016/j.bmc.2009.02.011. Epub 2009 Feb 14.

PMID:
19254848
28.

[Nocturnal hemodialysis: an alternative treatment for a better quality of life].

Tartaglia L, Infante B, Stallone G, Cirillo P, Liuzzi M, Ktena M, Forcella M, Querques M, Perulli R, Procaccini DA, Gesualdo L.

G Ital Nefrol. 2008 Nov-Dec;25(6):702-7. Italian.

PMID:
19048571
29.

Synthesis and antiviral evaluation of 4-fluoropyrazole-3-carboxamide nucleoside derivatives.

Leroy F, Chaves D, Dukhan D, Storer R, Sommadossi JP, Loi AG, Cadeddu A, Fanti M, Boscu N, Bassetti F, Liuzzi M, Gosselin G.

Nucleic Acids Symp Ser (Oxf). 2008;(52):617-8. doi: 10.1093/nass/nrn312.

PMID:
18776531
30.

Synthesis and antiviral evaluation of a seven-membered sugar ring nucleoside analog, 9-(5-deoxy-beta-D-allo-septanosyl)-adenine.

Sizun G, Griffon JF, Griffe L, Dukhan D, Storer R, Sommadossi JP, Loi AG, Musiu C, Poddesu B, Cadeddu A, Fanti M, Boscu N, Bassetti F, Liuzzi M, Gosselin G.

Nucleic Acids Symp Ser (Oxf). 2008;(52):611-2. doi: 10.1093/nass/nrn309.

PMID:
18776528
31.

Synthesis and study of 9-deazaguanosine derivatives as potential inhibitors of RNA virus replication.

Hamann M, Pierra C, Storer R, Sommadossi JP, Loi AG, Cadeddu A, Fanti M, Boscu N, Bassetti F, Liuzzi M, Gosselin G.

Nucleic Acids Symp Ser (Oxf). 2008;(52):603-4. doi: 10.1093/nass/nrn305.

PMID:
18776524
32.

Synthesis and antiviral evaluation of 7-fluoro-7-deaza-2-aminopurine nucleoside derivatives.

Leroy F, Chaves D, Dukhan D, Storer R, Sommadossi JP, Loi AG, Cadeddu A, Fanti M, Boscu N, Bassetti F, Liuzzi M, Gosselin G.

Nucleic Acids Symp Ser (Oxf). 2008;(52):595-6. doi: 10.1093/nass/nrn301.

PMID:
18776520
33.

Antithrombin after cardiac surgery: implications on short and mid-term outcome.

Paparella D, Cappabianca G, Scrascia G, Fiore G, Paramythiotis A, Di Bari N, Liuzzi MP, Ibrahim MF, Fiore T, de Luca Tupputi Schinosa L.

J Thromb Thrombolysis. 2009 Jan;27(1):105-14. doi: 10.1007/s11239-007-0191-9. Epub 2008 Jan 11.

PMID:
18188510
34.

2'-C-Methyl branched pyrimidine ribonucleoside analogues: potent inhibitors of RNA virus replication.

Benzaria S, Bardiot D, Bouisset T, Counor C, Rabeson C, Pierra C, Storer R, Loi AG, Cadeddu A, Mura M, Musiu C, Liuzzi M, Loddo R, Bergelson S, Bichko V, Bridges E, Cretton-Scott E, Mao J, Sommadossi JP, Seifer M, Standring D, Tausek M, Gosselin G, La Colla P.

Antivir Chem Chemother. 2007;18(4):225-42.

PMID:
17907380
35.

Evolution of the thienopyridine class of inhibitors of IkappaB kinase-beta: part I: hit-to-lead strategies.

Morwick T, Berry A, Brickwood J, Cardozo M, Catron K, DeTuri M, Emeigh J, Homon C, Hrapchak M, Jacober S, Jakes S, Kaplita P, Kelly TA, Ksiazek J, Liuzzi M, Magolda R, Mao C, Marshall D, McNeil D, Prokopowicz A 3rd, Sarko C, Scouten E, Sledziona C, Sun S, Watrous J, Wu JP, Cywin CL.

J Med Chem. 2006 May 18;49(10):2898-908.

PMID:
16686533
36.

Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.

Liuzzi M, Mason SW, Cartier M, Lawetz C, McCollum RS, Dansereau N, Bolger G, Lapeyre N, Gaudette Y, Lagacé L, Massariol MJ, Dô F, Whitehead P, Lamarre L, Scouten E, Bordeleau J, Landry S, Rancourt J, Fazal G, Simoneau B.

J Virol. 2005 Oct;79(20):13105-15.

37.

Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.

Bolger G, Lapeyre N, Dansereau N, Lagacé L, Berry G, Klosowski K, Mewhort T, Liuzzi M.

Can J Physiol Pharmacol. 2005 Feb;83(2):198-213. Erratum in: Can J Physiol Pharmacol. 2005 Mar;83(3):319.

PMID:
15791294
38.

Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase.

Liuzzi M, Kibler P, Bousquet C, Harji F, Bolger G, Garneau M, Lapeyre N, McCollum RS, Faucher AM, Simoneau B, Cordingley MG.

Antiviral Res. 2004 Dec;64(3):161-70.

PMID:
15550269
39.

Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor.

Mason SW, Lawetz C, Gaudette Y, Dô F, Scouten E, Lagacé L, Simoneau B, Liuzzi M.

Nucleic Acids Res. 2004 Sep 8;32(16):4758-67. Print 2004.

40.
41.

Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.

Duan J, Liuzzi M, Paris W, Liard F, Browne A, Dansereau N, Simoneau B, Faucher AM, Cordingley MG.

Antimicrob Agents Chemother. 2003 Jun;47(6):1798-804.

42.

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.

Crute JJ, Grygon CA, Hargrave KD, Simoneau B, Faucher AM, Bolger G, Kibler P, Liuzzi M, Cordingley MG.

Nat Med. 2002 Apr;8(4):386-91.

PMID:
11927945
43.

Usefulness of endoscopic small intestinal biopsies in children with coeliac disease.

Magliocca FM, Bonamico M, Petrozza V, Danesi H, Liuzzi M, Velucci O, Carpino F.

Ital J Anat Embryol. 2001;106(2 Suppl 1):329-35.

PMID:
11729974
44.

[Non-Hodgkin's lymphoma in multiple places and uterine involvement].

La Torre F, Petrozza V, Nicastro A, Nicolai AP, Scialpi R, Liuzzi M, Carpino F.

Chir Ital. 2000 Jul-Aug;52(4):441-5. Italian.

PMID:
11190537
45.

Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies.

Chignola R, Cestari T, Guerriero C, Riviera AP, Ferrari S, Brendolan A, Gobbo M, Amato S, Sartoris S, Fracasso G, Liuzzi MG, Riccio P, Tridente G, Andrighetto G.

Clin Exp Immunol. 2000 Dec;122(3):429-36.

46.

Radiation inactivation of ribonucleotide reductase, an enzyme with a stable free radical.

Bolger G, Liuzzi M, Krogsrud R, Scouten E, McCollum R, Welchner E, Kempner E.

Biophys J. 2000 Oct;79(4):2155-61.

47.

Purification and characterization of a novel human acidic nuclease/intra-cyclobutyl-pyrimidine-dimer-DNA phosphodiesterase.

Famulski KS, Liuzzi M, Bashir S, Mirzayans R, Paterson MC.

Biochem J. 2000 Feb 1;345 Pt 3:583-93.

48.

Dose and duration-dependence of ganciclovir treatment against murine cytomegalovirus infection in severe combined immunodeficient mice.

Duan J, Paris W, Kibler P, Bousquet C, Liuzzi M, Cordingley MG.

Antiviral Res. 1998 Oct;39(3):189-97.

PMID:
9833959
50.

Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.

Duan J, Liuzzi M, Paris W, Lambert M, Lawetz C, Moss N, Jaramillo J, Gauthier J, Déziel R, Cordingley MG.

Antimicrob Agents Chemother. 1998 Jul;42(7):1629-35.

Supplemental Content

Loading ...
Support Center